非体外循环下冠脉搭桥术的围术期管理

目的：比较非体外循环搭桥术与体外循环搭桥术病人的术中及术后早期恢复情况。方法39例病人接受了非体外循环下冠脉搭桥术,同时期33例病人接受了体外循环冠脉搭桥术。两组均采用中等剂量阿片静脉复合全麻,结果：病人的麻醉时间、手术时间、术后机械通气时间和在监护室的停留时间,非体外循环组明显短于体外循环组（P＜0．01）。围术期平均输血量和血血病人数在1支桥病人中非体外循环组明显少于体外循环组（P＜0．05）。术后房颤发生率和围术期心肌梗死发生率两组间无明显差异,术后脑卒中,低心排及死亡的发生率各组均为0％。结论与外循环搭桥术相比,非体外循环搭桥术缩短了病人的麻醉、手术及在监护室停留时间,加快了病人的恢复、从耐而提高了手术的安全性,并降低了手术费用。     

Effects of amrinone in patients undergoing off-pump coronary artery bypass grafting

We evaluated the effect of amrinone in 41 patients undergoing off-pump coronary artery bypass grafting(CABG) retrospectively. Amrinone was intravenously administered at the rate of 5 mcg.kg-1.min-1 after coronary artery anastomosis (A 1 group: 11 cases) or after induction of anesthesia(A 2 group: 13 cases). The hemodynamic variables and use of concomitant drugs were compared among A 1, A 2 and the non-amrinone group (control group: 17 cases). Hemodynamics was measured before, during, after coronary artery anastomosis, and after the chest closure. Catecholamine and vasodilator were used to maintain mean arterial pressure (> 60 mmHg) and cardiac index(> 3.0 l.min-1.m-2). Mean pulmonary artery pressure, right atrial pressure and pulmonary artery wedge pressure were significantly higher during anastomosis than before anastomosis in control and A 1 group, but no significant changes in these parameters were observed in A 2 group. In addition, these variables increased significantly after chest closure in control group, but were unchanged in A 1 and A 2 groups. Patients with concomitant use of catecholamine and vasodilator in A 2 group were fewer than those in control and A 1 group. In conclusion, in the patients undergoing off-pump CABG, infusion of amrinone was recommended from the end of the induction of anesthesia.     

Perioperative myocardial infarction in patients undergoing off-pump coronary artery bypass grafting

Two patients in whom myocardial infarction in the inferior wall occurred after off-pump coronary artery bypass grafing (OPCAB) are described. In both patients, the right coronary artery had no critical lesion and was not grafted. There was no ischemic episode during operation. Coronary artery spasms and/or intracoronary thrombus formation may have been causes of these events. To our knowledge, this is the first report on perioperative myocardial infarction in OPCAB.     

Effects of olprinone hydrochloride in patients undergoing off-pump coronary artery bypass grafting

BACKGROUND: Olprinone hydrochloride (OLP) is a new phosphodiesterase III inhibitor with positive inotropic and vasodilator properties. It is characterized by strong inotropic effect and relatively weak vasodilating effect. Although the method for administration of OLP has been reasonably optimized, no studies have examined the administration mode for patients with off-pump coronary artery bypass grafting (OPCAB). METHODS: After the start of the operation, 12 patients received OLP 0.2 microg x kg(-1) x min(-1) (OLP group) and 14 patients received normal saline (control group). Catecholamines were concomitantly administered to maintain systolic pressure > or = 100 mmHg and cardiac index (CI) > or = 2.5 l x min(-1) x m(-2). Hemodymanic parameters were measured after induction of anesthesia, at the administration of heparin, immediately after coronary artery anastomosis, at the end of the operation, and 3 h and 6 h after the operation. RESULTS: Systolic and mean arterial pressures did not differ between the two groups. CI was significantly increased, and SVRI was significantly decreased after administration of heparin, immediately after coronary artery anastomosis, at the end of the operation and 3 h after the operation in the OLP group. OLP reduced the number of patients requiring dopamine and dobutamine compared with the control group. CONCLUSIONS: The study showed that OLP administrated during OPCAB may have improved hemodynamics in patients for OPCAB.     

右美托咪啶对非体外循环冠状动脉旁路移植术患者心肌损伤的影响

目的 评价右美托咪啶对非体外循环冠状动脉旁路移植术患者心肌损伤的影响.方法 择期非体外循环冠状动脉旁路移植术患者46例,性别不限,ASA分级Ⅱ或Ⅲ级,年龄37～64岁,采用随机数字表法,将其随机分为2组(n=23),两组麻醉诱导及麻醉维持方法相同.右美托眯啶组(D组)于麻醉诱导后持续静脉输注右美托咪啶0.5 μg·kg-1∶h-1至术毕,对照组(C组)给予等容量生理盐水.分别于手术开始、血管吻合完毕、血管吻合完毕后30 min和术毕时记录平均肺动脉压、肺毛细血管楔压;中心静脉压和心输出量,计算每搏指数、左室每搏功指数、右室每搏功指数、周围血管阻力和肺血管阻力.分别于麻醉诱导前、术毕、术后4 h和术后24 h时采集静脉血样,采用ELISA法测定血浆心肌肌钙蛋白Ⅰ浓度.结果 与C组比较,D组术毕时每搏指数和左室每搏功指数升高,血管吻合完毕后30 min和术毕时周围血管阻力降低,术后24 h时血浆cTnI浓度降低(P＜0.05);其余血液动力学指标组间差异无统计学意义(P＞0.05).结论 术中静脉输注右美托咪啶0.5 μg·kg-1·h-1可减轻非体外循环冠状动脉旁路移植术患者心肌损伤.

Abstract：

Objective To evaluate the cardioprotective effect of dexmedetomidine in patients undergoing off-pump coronary artery bypass grafting. Methods Forty-six ASA Ⅱ or Ⅲ patients aged 37-64 yr weighing 54-81 kg undergoing off-pump coronary artery bypass grafting were randomized into 2 groups ( n = 23 each): control group (group C) and dexmedetomidine group (group D) . Dexmedetomidine was infused at 0.5 μg·kg-1·h-1 starting after induction of anesthesia until the end of operation in group D. Radial artery was cannulated and Swan-Ganz catheter placed via right internal jugular vein. HR, MAP, mean pulmonary arterial pressure, pulmonary capilary wedge pressure, central venous pressure, and cardiac output were recorded and stroke volume index, left and right ventricular stroke work index, systemic vascular resistance and pulmonary vascular resistance were calculated at the beginning of operation (T1 ), immediately (T2 ) and at 30 min after reestablishment of coronary blood flow (T3 ) and the end of operation (T4 ) . Venous blood samples were taken before induction of anesthesia (T0 , baseline) , at T4 and 4 h (T5 ) and 24 h (T6 ) after operation for determination of plasma concentration of cardiac troponin I by ELISA. Results Stroke volume index and left ventricular stroke work index were significantly higher at T4 while systemic vascular resistance was lower at T34 in group D than in group C. Plasma cardiac troponin Ⅰ concentration was significantly lower at T6 in group D than in group C. Conclusion Dexmedetomidine infusion at 0.5 μg ·kg-1·h-1 during operation can protect myocardium in patients undergoing off-pump coronary artery bypass grafting.     

心肌特异性脂肪酸结合蛋白在不停跳冠状动脉搭桥术中的变化

Objective To appraise the sensitivity of hFABP for myocardial ischemia in patients undergoing off-pump coronary artery bypass grafting among cardiac markers. Methods Thirty-eight consecutive patients undergoing OPCABG were included in a randomized study using standardized operative procedures and myocardial protection. Serial blood samples were taken preoperatively, during anastomoses, at the end of operation, 6 h, 18 h and 36 h postoperatively and tested for hFABF,Troponin Ⅰ （cTnⅠ） ,sCD40L,creatine kinase isoenzyme （CK-MB）. Results Six cases （16.7%） were found myocardial injury during the OPCABG by ECG or PAP. Their serial serum hFABP,cTnⅠ,sCD40L, CK-MB were higher than those without myocardial injury. The peak serum level of hFABP was higher and occurred earlier than those of cTnⅠ, sCD40L,CK-MB. Conclusion These results suggest that serum hFABP is an early and sensitive biochemical marker for the diagnosis of myocardial injury in patients undergoing OPCABG.     

Anaesthesia for off-pump coronary artery bypass grafting surgery

Coronary artery bypass grafting (CABG) surgery may be undertaken with or without cardiopulmonary bypass (CPB), that is, on- or off-pump. Traditional high-dose opioid techniques of general anaesthesia should be avoided and either inhalation or total intravenous (IV) anaesthesia may be used. Meticulous monitoring, including electrocardiograph and invasive arterial pressure measurement, is required. During grafting, good communication between anaesthetist and surgeon is essential. Maintenance of diastolic arterial pressure (DAP) is the key to preventing myocardial ischaemia and cardiovascular collapse. Surgical positioning for grafting to minimize hypotension is paramount and during grafting, IV fluid loading or vasoconstrictors and inotropes are effective treatments. Correction of bradycardia with atropine 0.3 mg IV or epicardial pacing also helps to maintain DAP. Persisting hypotension may require intra-aortic balloon pumping or conversion to on-pump CABG surgery. As there is less blood loss, there is a minimal requirement for cardiovascular support and early recovery of consciousness associated with off-pump compared with on-pump CABG surgery; patients in some institutions may be managed in a recovery room then transferred to a high-dependency unit, thus bypassing the intensive care unit.     

Anaesthesia for off-pump coronary artery bypass grafting surgery

Coronary artery bypass grafting (CABG) surgery may be undertaken with or without cardiopulmonary bypass (CPB) that is on- or off-pump. Although mortality and the incidences of coronary artery graft occlusion, myocardial infarction and stroke are equivalent, off-pump is associated with less blood loss, transfusion, requirement for inotropes, atrial fibrillation and chest infection compared with on-pump CABG surgery. Traditional high-dose opioid techniques of general anaesthesia should be avoided and either inhalation or total intravenous (IV) anaesthesia may be used. Meticulous monitoring, including electrocardiograph (ECG) and invasive arterial pressure measurement, is required. During grafting, good communication between anaesthetist and surgeon is essential. Maintenance of diastolic arterial pressure (DAP) is the key to preventing myocardial ischaemia and cardiovascular collapse. Surgical positioning for grafting to minimize hypotension is paramount and during grafting, IV fluid loading or vasoconstrictors and inotropes are effective treatments. Correction of bradycardia with atropine 0.3 mg IV or epicardial pacing also helps to maintain DAP. Persisting hypotension may require intra-aortic balloon pumping or conversion to on-pump CABG surgery. As there is less blood loss, there is a minimal requirement for cardiovascular support and early recovery of consciousness associated with off-pump compared with on-pump CABG surgery; patients in some institutions may be managed in a recovery room then transferred to a high-dependency unit, thus bypassing ICU.     

Nonthyroidal illness syndrome in off-pump coronary artery bypass grafting

BACKGROUND: Cardiopulmonary bypass (CPB) is an established cause of nonthyroidal illness syndrome (NTIS). Off-pump coronary artery bypass (OPCAB) has been reported to be less invasive than coronary artery bypass grafting (CABG) with CPB. We prospectively evaluated thyroid metabolism in OPCAB patients. METHODS: We analyzed free thyroid hormones (FT3 and FT4), thyroid-stimulating hormone (TSH), and reverse T3 (rT3) in 20 consecutive patients undergoing CABG surgery. Nine patients underwent CABG with CPB, and 11 underwent OPCAB. Blood samples were taken on admission, on the day of surgery (7:30 AM), after sternotomy, at the end of the operation, and at 2, 6, 12, 24, 36, 48, 72, 96, 120, and 144 hours postoperatively. The concentrations of FT3, FT4, and TSH were determined on each sample. Reverse T3 concentration was measured in 10 patients up to 48 hours and at 144 hours postoperatively. RESULTS: Baseline, operative, and postoperative variables were similar in the two groups. FT3 concentration dropped significantly (p < 0.0001), reaching its lowest value 12 hours postoperatively. There were no significant differences between CPB and OPCAB patients. FT4 varied significantly in both groups (p < 0.0001), but remained in the normal range. TSH variation was not significant. rT3 concentration rose significantly (p = 0.0002) in both groups, peaking 24 hours after surgery. CONCLUSIONS. OPCAB induces a NTIS similar to that observed after CPB, probably due to the inhibition of T4 conversion to T3. This finding suggests that NTIS is a nonspecific response to stress. CPB should not be considered as the sole trigger of NTIS in cardiac surgical patients.     

地尔硫(艹卓)在非体外循环下冠状动脉搭桥术围术期的心肌保护作用

目的 探讨非体外循环下冠状动脉搭桥术(OPCABG)围术期输注地尔硫(艹卓)对心肌的保护作用.方法 40例择期手术患者,随机分为地尔硫(艹卓)组(D组)与硝酸甘油组(C组),每组20例.D组静脉给予地尔硫(艹卓)0.1 mg·kg-1·h-1至术后24 h,C组常规给予硝酸甘油0.1μg·kg-1·h-1至术后24 h.分别在术毕、术后1、3、6、12和24 h记录血流动力学参数,并采集血样测定血清肌钙蛋白Ⅰ(cTnI).结果 与C组比较,D组的心率术后1、3、6、12、24 h均较慢(P＜0.05).C组房颤4例,D组1例;C组室上性心动过速5例,D组1例.术后6 h的cTnI,D组显著低于C组(P＜0.05).结论 OPCABG围术期持续输注地尔硫(艹卓)有比硝酸甘油更好的抗缺血和抗心律失常的保护作用.     

丙泊酚麻醉对不停跳冠脉搭桥患者围术期心肌肌钙蛋白T水平的影响

目的 研究丙泊酚麻醉对不停跳冠脉搭桥患者围术期心肌肌钙蛋白T(cTnT)水平的影响。方法 28例择期接受不停跳冠状动脉搭桥手术的患者依据麻醉维持方法的不同分为对照组(Ⅰ组，13例)和丙泊酚组(Ⅱ组，15例)。Ⅰ间断静注芬太尼加1％异氟醚吸入；Ⅱ组持续输注丙泊酚加1％异氟醚吸入。分别于入手术室(T0)、麻醉诱导平稳后(T1)、手术结束即刻(TST)、术后4h(T1)、8h(T8)、12h(T12)、24h(T34)和48h(T48)抽静脉血2ml测定cTnT。结果 两组患者T0和T1时cTnT正常，术后则显著性升高，高峰都出现在术后8h。两组之间相比，虽然丙泊酚组在大多数时间点上(术后即刻一术后24h)cTnT值比芬太尼组稍低，但无显著性差异。结论 本研究未发现临床剂量的丙泊酚能减轻心脏手术对心肌的损伤。     

Application of off-pump coronary artery bypass grafting for patients with acute coronary syndrome requiring emergency surgery.

Off-pump coronary artery bypass grafting (OPCAB) has become a more applicable procedure, even in patients with multi-vessel disease. However, the role of OPCAB for patients with acute coronary syndrome (ACS) requiring emergency revascularization has not been established yet. We reviewed our results of emergency coronary artery bypass grafting (CABG) for patients with ACS. Seventy-two patients with ACS who underwent emergency CABG were studied. Twenty-five underwent OPCAB and 47 on-pump CABG. OPCAB was mainly indicated for patients who were possibly at risk for cardiopulmonary bypass. When the coronary anatomy was suitable in younger or less risky patients, OPCAB was performed. Patients with multi-vessel disease or with a critical left main trunk lesion were not excluded from OPCAB. The mean number of grafted vessels was 2.6 per patient in the OPCAB group, and 3.8 per patient in the on-pump group (p<0.0001). However, none of the patients in either group required postoperative catheter intervention. Mean operative time was 195 minutes in the OPCAB group and 286 minutes in the on-pump group (p<0.0001). There were three postoperative deaths in the OPCAB group and four in the on-pump group. Multivariate logistic regression analysis revealed that preoperative cardiogenic shock was the only significant predictor for postoperative death (odds ratio, 7.33). The selection of the on-pump procedure or OPCAB did not correlate with operative death. Thus, we conclude that OPCAB can be performed safely and effectively in selected patients with ACS requiring emergency coronary revascularization.     

吗啡-芬太尼复合麻醉下非体外循环冠状动脉旁路移植术患者的转归

目的 探讨吗啡-芬太尼复合麻醉下非体外循环下冠状动脉旁路移植术患者的转归.方法 拟在非体外循环下行冠状动脉旁路移植术的患者72例,年龄41～64岁,随机分为2组(n=36):芬太尼复合麻醉组(F组)和吗啡-芬太尼复合麻醉组(MF组).静脉注射芬太尼10～20μg/kg、咪达唑仑0.1 mg/kg、依托咪酯0.3 mg/kg和维库溴铵0.1 mg/kg进行麻醉诱导,气管插管后行机械通气.麻醉维持:MF组静脉输注吗啡0.15 mg·kg-1·h-1+芬太尼8μg·kg-1·hZ-1,F组静脉输注芬太尼10μg·kg-1·h-1,2组均吸入0.5%～2.0%异氟烷,间断静脉注射维库溴铵4 rag.2组术后进行静脉镇痛,MF组和F组分别静脉输注吗啡0.75 mg/h吗啡和芬太尼10μg/h.分别于术前(基础状态)、术后1、2、3 d进行恢复质量评分(QoR评分).于拔除气管导管后15 min、4 h、24 h时进行Ramsay镇静评分.记录术后不良反应的发生情况.结果 与F组比较,MF组术后QoR评分升高,术后发热发生率降低(P＜0.05或0.01),Ramsay镇静评分和其他不良反应的发生率差异无统计学意义(P＞0.05).结论与芬太尼复合麻醉比较,吗啡-芬太尼复合麻醉有利于非体外循环下冠状动脉旁路移植术患者预后.     

心脏不停跳非体外循环冠状动脉旁路移植术的进展

近年来，随着手术器械的发展，心脏不停跳非体外循环下冠状动脉旁路移植术(OPCAB)逐渐被广泛接受和应用。与常规冠状动脉旁路移植术(CCABG)比较，OPCAB的主要优势为血液中多种炎性介质浓度明显降低，避免了体外循环(CPB)带来的全身系统性炎性损害，减少了并发症，降低了手术死亡率。特别对那些不能采用CPB或采用CPB有风险的高危患者优势更明显。CCABG的手术适应证同样适用于OPCAB，但OPCAB具有相对的禁忌证。OPCAB多采用胸骨正中切口，左前外侧切口适用于左前降支单支病变。OPCAB术后早期结果类似CCABG，但中远期结果有待进一步观察。OPCAB大多数旁路移植血管数低于CCABG，有不能完全再血管化的可能，对OPCAB是否会影响吻合的精确性和旁路血管的长期通畅率有不同意见。OPCAB的优势明确，但仍不能完全替代CCABG，手术的同时应作好CPB准备，必要时改行CCABG。     

依达拉奉对非体外循环冠脉搭桥术患者心肌损伤的影响

目的 评价依达拉奉对非体外循环冠脉搭桥术患者心肌的保护作用.方法 择期非体外循环下冠脉搭桥术患者40例,ASA分级Ⅲ或Ⅳ级,NYHA心功能Ⅱ或Ⅲ级,年龄45～64岁,体重55～95 kg,性别不限.采用随机数字表法,分为试验组(E组,n=20)和对照组(C组,n=20).在麻醉诱导后,E组静脉输注依达拉奉60 mg,给药时间30 min,C组给予等容量生理盐水.于术前(T1)、切皮后1 h(T2)、术毕(T3)和术后24 h(T4)分别取静脉血标本,测定血清心肌酶及肌钙蛋白Ⅰ(cTnI)水平.记录患者术后呼吸机治疗时间、ICU停留时间及住院时间.结果 与C组比较,E组血清肌酸激酶、肌酸激酶同工酶及乳酸脱氢酶的活性和cTnI浓度,T1时差异无统计学意义(P＞0.05);T3,4时均明显升高(P＜0.05);与T1时比较,T3,4时两组以上指标均明显升高(P＜0.05).术后呼吸机治疗时间、ICU停留时间及住院时间E组较C组明显缩短(P＜ 0.05或0.01).结论 非体外循环下冠脉搭桥术开始前静脉输注依达拉奉60 mg,可产生有效的心肌保护作用.     

Urgent off-pump coronary artery bypass grafting

OBJECTIVES: The use of off-pump coronary artery bypass grafting (CABG) has become widespread, since it has proven less invasive and to promote early recovery. In this study, we investigated the efficacy of off-pump CABG in patients in the evolving phase of acute myocardial infarction. METHODS: Retrospective chart review was carried out for patients undergoing urgent isolated off-pump and on-pump CABG at Shin-Tokyo Hospital Group between January 1991 and June 2001. The patients' demographic, operative data, and postoperative results were collected. RESULTS: The off-pump group consisted of 19 males and 11 females with a mean age of 72.0 years and the on-pump group of 91 males and 38 females with a mean age of 64.3 years. Preoperative use of intraaortic balloon pumping and preoperative shock was more frequently observed in the on-pump group. The mean number of distal anastomoses was 3.1 +/- 0.9 in the off-pump group and 3.2 +/- 1.1 in the on-pump group (p = NS). Intubation time (18.5 vs 32.9 hours), ICU stay (3.4 vs 4.9 days), and postoperative stay (13.5 vs 24.3 days) were significantly shorter in the off-pump group than in the on-pump group (P < 0.05). The frequency of the major complications was significantly lower in the off-pump group (9/30, 30%) than the on-pump group (65/129, 50.4%), especially for postoperative low output syndrome (p < 0.05). Multivariate analysis demonstrated a significant reduction in the recovery period by use of off-pump CABG. Early follow-up results were similar between the two groups, in terms of late cardiac events and survival. CONCLUSION: Urgent off-pump CABG is safe and provides early recovery, provided that the patient's intraoperative hemodynamics are taken into account.     

Usefulness of perioperative blood glucose control in patients undergoing off-pump coronary artery bypass grafting

Objective We investigated the usefulness of perioperative blood glucose control in patients undergoing coronary artery bypass grafting (CABG). Methods DM patients were aggressively treated with intensive insulin therapy to achieve a preoperative fasting blood glucose level of 140 mg/dl and a postoperative level of 200 mg/dl. For comparison, patients were divided as follows: (1) DM group vs. non-DM group, and (2) for mean blood glucose level in the intensive care unit (ICU), lower than 200 mg/dl (IL) vs. 200 mg/dl or higher (IH). Results (1) In the DM group, the amount of insulin (U) used during surgery was greater (P < 0.05), and the duration of ICU stay was longer (P < 0.05). The incidence of all complications was higher in the DM group (P < 0.05). (2) Between the IH group (54) and the IL group (82), the proportion of DM patients was higher in the IH group (75% vs. 38%, P < 0.05). In the IH, the duration of ICU stay (P < 0.01) was longer, and the incidence of all complications was higher (P < 0.05). (3) In the DM group, the incidence of complications tended to be higher in the IH group. The incidence of complications was extremely low in the non-DM group. Conclusion Strict perioperative blood glucose control may help to improve the outcomes of CABG.     

Mild or moderate ischemic mitral regurgitation in patients undergoing off-pump coronary artery bypass grafting

BACKGROUND: There has been a debate, whether mild or moderate ischemic mitral regurgitation (IMR) should be repaired at the time of coronary bypass surgery. We assessed the early and midterm outcomes of patients with mild or moderate IMR who underwent isolated off-pump coronary artery bypass grafting (OPCAB). METHODS: We retrospectively reviewed records of 602 patients who underwent OPCAB between April 2001 and July 2004. Of those, 96 patients had mild or moderate MR (IMR group), and 506 had none or trivial MR (no IMR group). Preoperative and postoperative characteristics were compared between the groups. Furthermore, fates of grade of MR and functional status were investigated in patients with IMR. RESULTS: The preoperative mean New York Heart Association (NYHA) classes were 2.7 +/- 1.0 and 2.4 +/- 0.9 in the IMR and no IMR groups, respectively (p < 0.01). Operative mortality was similar between groups (1.0% in the IMR group and 0.4% in no IMR group, p = 0.41). The cumulative survival rate for the IMR group was 93.7% at 1 year and 90.1% at 4 years. The mean NYHA class was 1.1 +/- 0.4 (p < 0.0001) at 28.8 +/- 11.4 months after operation for the IMR group. The mean grade of mitral regurgitation diminished (from 2.2 +/- 0.4 to 1.1 +/- 0.6, p < 0.0001) soon after operation in patients with IMR, and remained so (1.1 +/- 0.8, p < 0.0001) during the follow-up period. CONCLUSIONS: Mild or moderate IMR could be improved with isolated OPCAB. The early and midterm functional outcomes of these patients were favorable.